NOT KNOWN DETAILS ABOUT PONSEGROMAB

Not known Details About Ponsegromab

In medical trials evaluating the utmost tolerated dose of gemcitabine for injection, prolongation from the infusion time further than 60 minutes or maybe more Repeated than weekly dosing resulted in an elevated incidence of clinically considerable hypotension, extreme flu-like signs, myelosuppression, and asthenia.Posterior reversible encephalopath

read more